This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Emcure Pharmaceuticals Limited With a market cap of Rs. Foreign investor BC Investments IV Limited offloaded around 45 lakh equity shares, equivalent to a 2.37 As per the latest shareholding pattern with the BSE, BC Investments IV Limited held an 8.68 Please consult your investmentadvisor before investing.
Emcure Pharmaceuticals Emcure Pharmaceuticals Limited’s stock, with a market capitalisation of Rs. According to CNBC-TV18, BC Investments IV, backed by Bain Capital, is planning to sell a 2.4% As of March 2025 , BC Investments IV held an 8.68% stake in Emcure Pharmaceuticals. 23,762 crores, fell to Rs.
Shares of a company involved in exporting, marketing & distributing finished formulations of pharmaceutical drugs and API surged nearly 3 percent on Tuesday, after the company announced record date for bonus issue in 1:1 ratio. the shares of Remus Pharmaceuticals Limited were trading in the green at Rs. With a market cap of Rs.
Aarti Pharmalabs Limited was established in 2019 and is engaged in manufacturing active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives. It is also engaged in contract development and manufacturing services for global pharmaceutical companies. per equity share, down nearly 2.18
The Other segment encompasses the distribution of pharmaceutical products and the company’s agribusiness initiatives, reflecting Nava’s strategic diversification into healthcare and agriculture. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing.
The company serves sectors like pharmaceuticals, agrochemicals, and industrial applications. Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals is a global pharmaceutical company headquartered in India, focused on generics, specialty, and over-the-counter (OTC) products. 4,950 on May 15, 2023.
Dr Reddy’s Laboratories Ltd Dr. Reddy’s Laboratories is a leading Indian pharmaceutical company known for manufacturing generic drugs, active pharmaceutical ingredients (APIs), and biosimilars. Investors must therefore exercise due caution while investing or trading in stocks.
The shares of prominent pharmaceutical companies gained up to 4 percent in today’s trading session after the company signed definitive agreements with global investment firm KKR to acquire a controlling stake in JB Chemicals & Pharmaceuticals worth Rs 25,689 crores on a fully diluted basis. per share, increasing around 0.19
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited was founded in 1907 and is an Indian multinational headquartered in Vadodara. It manufactures and markets pharmaceutical formulations, active pharmaceutical ingredients, and intermediates, with a strong presence in anti-infective drugs and global markets.
Here are three companies with a Six-months lock-in expiry on June 30, 2025 Senores Pharmaceuticals Limited With a market capitalization of Rs. crore, the shares of Senores Pharmaceuticals Limited were currently trading at Rs. On June 30, 2025, the six-month lock-in period for Senores Pharmaceuticals ends, unlocking 2.2
Cohance Lifesciences Cohance Lifesciences is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals, and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies.
Zota Health Care Limited is a drug development, manufacturing and marketing company, offering a wide range of pharmaceutical, nutraceutical, ayurvedic and OTC products in India and overseas as well. Investors must therefore exercise due caution while investing or trading in stocks. Further, the company reported a revenue of Rs.
Glenmark Pharmaceuticals Limited Glenmark Pharmaceuticals Limited was established in 1977 and is engaged in the research, development, manufacturing, and marketing of pharmaceutical formulations and active pharmaceutical ingredients, focusing on oncology, respiratory, and dermatology segments globally.
This small-cap Pharma Stock, engaged in manufacturing and marketing pharmaceutical formulations and APIs, serving regulated and emerging markets with a focus on quality, compliance, and innovation, is in focus after management expected 50% growth in revenue and 100% growth in net profit for FY26. With a market capitalization of Rs.
Cipla Ltd Cipla Limited is a global pharmaceutical company headquartered in Mumbai, India, known for its wide range of medicines in respiratory, anti-retroviral, urology, cardiology, and other segments. Investors must therefore exercise due caution while investing or trading in stocks. The company is issuing a Final dividend of Rs.
While the total investment value remains unchanged, shareholders receive more shares, promoting broader ownership and trading activity. Anuh Pharma Ltd Anuh Pharma Limited is engaged in the business of manufacturing active pharmaceutical ingredients (API). Please consult your investmentadvisor before investing.
Suven Life Science Ltd Suven Life Science Ltd is a pharmaceutical and biotechnology company specializing in drug discovery and contract research services. It focuses on developing novel therapeutics for central nervous system disorders and collaborates with global pharmaceutical firms.
India is emerging as a major player in the pharmaceutical industry, particularly in developing cancer drugs. This growth creates immense opportunities for pharmaceutical companies specializing in oncology treatments. Venus Remedies Ltd Venus Remedies is a specialized pharmaceutical company focusing on oncology and anti-infective drugs.
RPG Life Sciences Limited is engaged in the business of manufacturing and marketing Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). Written by Shivani Singh Disclaimer The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in
It works with global clients, including biotech startups and large pharmaceutical firms, helping them bring new medicines to market. Strong global customer base, including large pharmaceutical and biotech companies. Robust R&D capabilities and investment in advanced technologies. 43.10, compared to Rs.
During Wednesday’s trading session, shares of a pharmaceutical company involved in manufacturing and selling tablets, capsules, and other healthcare products jumped nearly 17.3 shares of Accretion Pharmaceuticals Limited were trading in the green at Rs. shares of Accretion Pharmaceuticals Limited were trading in the green at Rs.
The shares of the Penny stock specializing in manufacturing and marketing a wide range of pharmaceutical formulations, hit a 5 percent upper circuit upon receiving two export sourcing orders valued at approximately Rs. Welcure Drugs & Pharmaceuticals Ltd. is an Indian pharmaceutical company that was incorporated in 1992.
The shares of this leading pharmaceutical company are in focus after the company secured the USFDA’s approval for its key drug used to treat ovarian cancer. With a market capitalisation of Rs 20,494 crores, the shares of Alembic Pharmaceuticals Ltd are currently trading at Rs 1,043 per share, down by 19.53 percent and 13.05
It manufactures and markets glass containers, PET bottles, and packaging solutions for beverages, pharmaceuticals, cosmetics, and other industries. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing. per share, up by 1.32
However, the Pharma index bucked the trend and posted gains, led by a significant rally in Glenmark Pharmaceuticals after a favourable licensing agreement. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing.
It is a leading manufacturer and supplier of industrial gases like oxygen, nitrogen, argon, helium, hydrogen, carbon dioxide, and more, catering to a wide range of industries such as steel, shipbuilding, glass, pharmaceuticals, and fabrication. Investors must therefore exercise due caution while investing or trading in stocks.
Mankind Pharma Ltd Mankind Pharma is one of India’s leading pharmaceutical companies. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing.
Murae Organisor Limited, formerly known as Earum Pharmaceuticals Limited, is primarily involved in the pharmaceutical sector. Its core activities include trading pharmaceutical products and acting as a commission agent for various pharma-related products. Please consult your investmentadvisor before investing.
The company provide end-to-end services across the drug discovery, development and manufacturing value chain, for small-molecule NCE to global pharmaceutical innovator companies and biotechnology firms. Investors must therefore exercise due caution while investing or trading in stocks.
One of India’s most trusted pharmaceutical names has just taken a major step to deepen its international presence. Zentiva is a leading pharmaceutical group with reach across 30+ countries across Europe and 100 million patients. Investors must therefore exercise due caution while investing or trading in stocks. 248 crore to Rs.
Marksans Pharma Limited is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing. on Wednesday.
Sun Pharmaceutical Industries Ltd. is a leading global pharmaceutical company based in India, renowned for its high-quality generic medications and specialty products. Founded in 1983, Sun Pharma has grown to become one of the largest pharmaceutical manufacturers in the world, serving over 150 countries.
Alkem Laboratories Limited Alkem Laboratories develops and manufactures pharmaceutical products across diverse therapeutic areas through 21 facilities in India and USA. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing.
Bliss GVS Pharma Limited was established in 1984 and is an Indian pharmaceutical company that develops, manufactures, and markets a wide range of affordable medicines and healthcare products, with global exports and leadership in suppositories and anti-malarial formulations. Please consult your investmentadvisor before investing.
This small-cap Pharma Stock, engaged in manufacturing active pharmaceutical ingredients (APIs) and conducting research and development to deliver high-quality, innovative healthcare solutions globally, jumped 6 percent after the promoter increased their stake by 4.16 Please consult your investmentadvisor before investing.
Its customer base spans sectors such as energy, metals, infrastructure, and pharmaceuticals, showcasing Suzlon’s wide market reach and strong trust among top corporations in renewable energy solutions. Investors must therefore exercise due caution while investing or trading in stocks. appeared first on Trade Brains.
K Sakai, with over a century of experience and a strong team, serves diverse industries including semiconductors, electronics, pharmaceuticals, and agrochemicals. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing.
During Friday’s trading session, shares of a global, research-driven pharmaceutical company engaged in developing and manufacturing a wide range of pharmaceutical products surged by around 1 percent on the BSE to Rs. Investors must therefore exercise due caution while investing or trading in stocks. 2,404 crores.
Top gainer/Top loser (Nifty 500) Top gainers Top losers Glenmark Pharmaceuticals Ltd. 4.7%) Hindustan Unilever Ltd Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing. crore, registering a 165% YoY growth compared to ₹34.04
Stocks like Glenmark Pharmaceuticals, Alkem Laboratories, and Ajanta Pharma led the sector with gains exceeding 1%. Glenmark Pharmaceuticals rose 14.55% on Friday, post the announcement that its subsidiary, IGI Therapeutics SA & AbbVie, got an exclusive global licensing agreement for the cancer and autoimmune drug ISB 2001.
The shares of this leading pharmaceutical company is in focus after shares worth Rs 879 crore exchanged hands via a block trade. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing.
DRIL sister concerns have operations in Polyester Yarn Spinning, Home Textiles, Pharmaceutical instruments, and Real Estate. Investors must therefore exercise due caution while investing or trading in stocks. Please consult your investmentadvisor before investing. With a market capitalization of Rs.
About the Company Divi’s Laboratories, founded in 1990 and based in Hyderabad, is one of India’s top pharmaceutical companies and a global leader in making APIs, intermediates, and nutraceutical ingredients. Investors must therefore exercise due caution while investing or trading in stocks.
One of the Micro-Cap pharmaceutical stocks engaged in manufacturing and marketing pharmaceutical and therapeutic products has hit a 5% upper circuit after reporting increased revenue by 235.66 The company produces a diverse portfolio of 832 products, including tablets, capsules, and various pharmaceutical formulations.
We organize all of the trending information in your field so you don't have to. Join 36,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content